EMA committee recommends approval for Sanofi's Sarclisa with carfilzomib, dexamethasone to treat multiple myeloma

Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for a second indication for Sarclisa (isatuximab), in combination